Other OTC - Delayed Quote USD

Blue Biofuels, Inc. (BIOF)

0.0884 +0.0053 (+6.42%)
At close: April 23 at 2:53 PM EDT
Loading Chart for BIOF
DELL
  • Previous Close 0.0831
  • Open 0.0989
  • Bid --
  • Ask --
  • Day's Range 0.0848 - 0.0989
  • 52 Week Range 0.0550 - 0.1850
  • Volume 66,000
  • Avg. Volume 110,408
  • Market Cap (intraday) 26.806M
  • Beta (5Y Monthly) -0.25
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date May 15, 2024 - May 20, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Blue Biofuels, Inc., through its subsidiaries, focuses on technologies in the renewable energy, biofuels, and bioplastics technologies sectors. The company develops Cellulose-to-Sugar (CTS 2.0), a mechanical/chemical dry process for converting cellulose material into sugar and lignin for use in the biofuels industry. It also has license for Vertimass Process to convert ethanol into bio-jet fuel. The company was formerly known as Alliance Bioenergy Plus, Inc. and changed its name to Blue Biofuels, Inc. in August 2021. Blue Biofuels, Inc. was incorporated in 2012 and is based in Palm Beach Gardens, Florida.

www.bluebiofuels.com

5

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BIOF

Performance Overview: BIOF

Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BIOF
7.85%
S&P 500
6.30%

1-Year Return

BIOF
46.40%
S&P 500
22.67%

3-Year Return

BIOF
71.84%
S&P 500
22.63%

5-Year Return

BIOF
145.65%
S&P 500
74.37%

Compare To: BIOF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BIOF

Valuation Measures

Annual
As of 4/23/2024
  • Market Cap

    26.81M

  • Enterprise Value

    30.29M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    -11.05

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -186.65%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -3.06M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    41.01k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -826.42k

Company Insights: BIOF

People Also Watch